Treatment of early stage of the follicular lymphoma by means of IF radio-therapy in combination with Rituximab

被引：0
|
作者：
Schmaus, M. C. [1 ]
Hensel, M. [1 ]
Herfarth, K. [1 ]
机构：
[1] Heidelberg Univ, Heidelberg, Germany
来源：
STRAHLENTHERAPIE UND ONKOLOGIE | 2008年 / 184卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：37 / 37
页数：1
相关论文
共 50 条
  • [31] Evaluating patterns of care for early-stage low-grade follicular lymphoma in the rituximab era
    Fenlon, Jordan B.
    Hutten, Ryan J.
    Johnson, Skyler B.
    Hu, Boyu
    Shah, Harsh
    Stephens, Deborah M.
    Maity, Amit
    Gaffney, David K.
    Tao, Randa
    LEUKEMIA & LYMPHOMA, 2023, 64 (02) : 356 - 363
  • [32] Early stage nodal follicular lymphoma using IF radiotherapy and Rituximab: Results of the MIR trial of the GLSG and ARO
    Herfarth, K.
    Schnaidt, S.
    Aro
    Glsg
    RADIOTHERAPY AND ONCOLOGY, 2014, 111 : S204 - S204
  • [33] Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma
    Czuczman, MS
    Koryzna, A
    Mohr, A
    Stewart, C
    Donohue, K
    Blumenson, L
    Bernstein, ZP
    McCarthy, P
    Alam, A
    Hernandez-Ilizaliturri, F
    Skipper, M
    Brown, K
    Chanan-Khan, A
    Klippenstein, D
    Loud, P
    Rock, MK
    Benyunes, M
    Grillo-Lopez, A
    Bernstein, SH
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (04) : 694 - 704
  • [34] Cladribine in combination with rituximab and IL-2 for untreated follicular lymphoma
    Fridrik, M
    ANNALS OF ONCOLOGY, 2005, 16 : 157 - 157
  • [35] Safety and activity of pembrolizumab in combination with rituximab in relapsed or refractory follicular lymphoma
    Nastoupil, Loretta J.
    Chin, Collin K.
    Westin, Jason R.
    Fowler, Nathan H.
    Samaniego, Felipe
    Cheng, Xiaoyun
    Ma, Man Chun John
    Wang, Zhiqiang
    Chu, Fuliang
    Dsouza, Ly
    Obi, Chizobam
    Mims, Jennifer
    Feng, Lei
    Zhou, Shouhao
    Green, Michael
    Davis, Richard Eric
    Neelapu, Sattva S.
    BLOOD ADVANCES, 2022, 6 (04) : 1143 - 1151
  • [36] Severe Anemia During Rituximab Maintenance Therapy for Follicular Lymphoma
    Liapis, Konstantinos
    Harhalakis, Nikolaos
    Stefanou, George
    Apostolidis, John
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (08) : E95 - E96
  • [37] Optimization of Postremission Therapy in Follicular Lymphoma: Efficacy of Rituximab Maintenance
    Roy, Rupali
    Gordon, Leo I.
    JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2011, 9 (05): : 563 - 571
  • [38] RESULTS OF MAINTENANCE THERAPY WITH RITUXIMAB IN FOLLICULAR NON HODGKIN LYMPHOMA
    Soria, B.
    Olave, M. T.
    Rubio-Escuin, R.
    Rubio-Martinez, A.
    Palomera, L.
    Fuertes, M. A.
    Mayayo, P.
    Recasens, V.
    Giraldo, P.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 112 - 112
  • [39] THE COST EFFECTIVENESS OF RITUXIMAB MAINTENANCE THERAPY IN PATIENTS WITH FOLLICULAR LYMPHOMA
    Mervin, M. C.
    VALUE IN HEALTH, 2016, 19 (03) : A153 - A153
  • [40] Meta analysis: Rituximab as maintenance therapy for patients with follicular lymphoma
    Vidal, Liat
    Gafter-Gvili, Anat
    Dreyling, Martin
    Ghielmini, Michele
    Hsu-Schmitz, Shu Fang
    Leonard, Leibovici
    Cohen, Amos
    Shpilberg, Ofer
    BLOOD, 2007, 110 (11) : 998A - 998A
12345